- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06379737
Multi-systemic Rehabilitative Interventions in Long COVID-19 Patients in Two Different Settings: a Randomized Controlled Trial (MULTI-COVID)
Valutazione Degli Esiti a Medio-lungo Termine Della Sindrome Long Covid in Pazienti Trattati Con un Protocollo di Riabilitazione in Ambiente Termale o in Teleriabilitazione
Objective: This study aimed to evaluate the effectiveness of a multisystem rehabilitation program for Long Covid patients in two different settings.
Design: Randomized controlled trial. Settings: Health resort and home-based. Participants: 72 Long Covid patients. Interventions: Patients were randomly assigned into two groups: Group A (n=36) received health resort intervention, and Group B (n=36) received home-based care. Both groups underwent a 5-week rehabilitation program, involving motor, respiratory, and cognitive exercises, two sessions per week.
Outcomes: Assessments were conducted before (T0) and after treatment (T1), at 3 (T2) and 6 months (T3), including respiratory and physical function, handgrip strength, fatigue, pain, quality of life, psychological function, and satisfaction.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At the outpatient clinics of the Neurorehabilitation Unit of the University Hospital of Padua, 103 patients were initially assessed. Out of these patients, 72 subjects of both genders with medium-to-long-term outcomes following previous infection with the SARS-CoV-2 virus were recruited for this study. Eight patients were excluded from the study due to initial assessments revealing conditions falling under exclusion criteria (1 patient lacked a prior diagnosis with a COVID-19 infection swab, 2 had concurrent tumor pathologies, 3 exhibited systemic inflammation, and 2 had skin infections), and 23 patients chose to undergo a rehabilitation program at a rehabilitative gym instead. Participants were randomly assigned to one of two rehabilitation treatment groups: the group treated at a health resort facility (Group A, n=36) and the group performing the exercise program at home (Group B, n=36). However, 6 patients did not complete follow-up assessments at different time points, resulting in the final evaluation of data collected from 66 patients, with 33 allocated to Group A and 33 to Group B (Fig. 1).
The patient enrollment was conducted between January 2023 and April 2023. Patients in group A underwent a 5-week rehabilitation cycle with two weekly sessions, totaling 10 sessions, in a health resort setting. The patients underwent treatments at two health resort facilities located in the Euganean Basin, Veneto, Italy, equipped with pools of the same depth, size, and water type. Patients in group B underwent a 5-week rehabilitation cycle at home with two weekly sessions, totaling 10 sessions.
At the beginning (T0) and at the end (T1) of the treatment, and during two subsequent follow-up times at 3 months (T2) and 6 months (T3), after the end of the treatment, patients in both groups were evaluated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Padova, Italy, 35128
- Universityof Padua
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
The inclusion criteria for the study included the following requirements: age between 18 and 75 years; a previous COVID-19 infection occurring between 6 and 18 months before our initial assessment; negative results in tests for the nucleic acid of the SARS-CoV-2 virus conducted on respiratory samples, such as oropharyngeal swabs; body temperature ≤ 37°C; presence of reduced cardio-respiratory capacity and/or motor deficits caused by the SARS-CoV-2 virus infection; manifestation of possible cognitive symptoms that could not be attributed to other conditions; no participation in cycles of thermal mineral-rich therapy in the six months preceding the study.
Exclusion criteria from the study included: inability to understand and sign the informed consent form; absence of a previous positive detection of nucleic acid of the SARS-CoV-2 virus in tests on respiratory samples; current positivity for the nucleic acid of the SARS-CoV-2 virus in respiratory samples; epilepsy, severe psychiatric disorders, neoplasms, or pregnancy. Moreover, commonly recognized contraindications for health resort treatments, such as skin infections or open wounds, systemic inflammation, heart, liver, respiratory, or kidney failure, and urinary or fecal incontinence, were considered additional exclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Home-based rehabilitation
Perform home-based rehabilitation
|
Patients in group A underwent a 5-week rehabilitation cycle with two weekly sessions, totaling 10 sessions, in a health resort setting. The patients underwent treatments at two health resort facilities located in the Euganean Basin, Veneto, Italy, equipped with pools of the same depth, size, and water type. Each session was structured into four components:
Patients in group B underwent a 5-week rehabilit |
|
Experimental: Health resort medicine rehabilitation
Perform Health resort medicine rehabilitation
|
Patients in group A underwent a 5-week rehabilitation cycle with two weekly sessions, totaling 10 sessions, in a health resort setting. The patients underwent treatments at two health resort facilities located in the Euganean Basin, Veneto, Italy, equipped with pools of the same depth, size, and water type. Each session was structured into four components:
Patients in group B underwent a 5-week rehabilit |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numerical Rating Scale (NRS)
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
a commonly used pain assessment tool that involves asking patients to rate their pain verbally or visually on a scale from 0 to 10, with 0 indicating no pain and 10 representing the worst possible pain
|
immediately before and after intervention and 3 and 6 months follow-ups
|
|
Hand grip strength
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
the strength of the dominant hand was assessed using a digital handheld dynamometer
|
immediately before and after intervention and 3 and 6 months follow-ups
|
|
Barthel Dyspnea Scale
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
The Barthel Dyspnea Scale is a validated tool used to measure the severity of dyspnea.
It evaluates various activities and tasks that may provoke dyspnea, allowing to assess and monitor the impact of dyspnea on a patient's daily life
|
immediately before and after intervention and 3 and 6 months follow-ups
|
|
Fatigue Assessment Scale
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
a self-report questionnaire designed to assess the severity and impact of fatigue.
It consists of 10 items, describing different aspects of fatigue.
|
immediately before and after intervention and 3 and 6 months follow-ups
|
|
Beck's Depression Inventory (BDI
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
the BDI is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression
|
immediately before and after intervention and 3 and 6 months follow-ups
|
|
Beck Anxiety Inventory (BAI)
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
the BAI is a self-report questionnaire designed to assess the severity of anxiety symptoms and consists of 21 items that measure various aspects of anxiety
|
immediately before and after intervention and 3 and 6 months follow-ups
|
|
12-Item Short Form Health Survey (SF-12)
Time Frame: immediately before and after intervention and 3 and 6 months follow-ups
|
The SF-12 is employed for assessing health-related quality of life (HRQoL).
It is a shortened version of the SF-36, consisting of 12 items that measure eight health domains, including physical functioning, limitations due to physical health problems, bodily pain, general health perception, vitality, social functioning, limitations due to emotional problems, and mental health
|
immediately before and after intervention and 3 and 6 months follow-ups
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients satisfaction
Time Frame: immediately after intervention
|
Specifically designed questionnaire (Likert scale)
|
immediately after intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Disease Attributes
- Chronic Disease
- Post-Infectious Disorders
- COVID-19
- Post-Acute COVID-19 Syndrome
Other Study ID Numbers
- 359n/AO/23
- MASI_CARIVARI21_01 (Other Grant/Funding Number: Fondazione Cariparo)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Long COVID
-
Fundacion Miguel ServetRecruiting
-
Miami VA Healthcare SystemNot yet recruiting
-
National Defense Medical Center, TaiwanCompletedLong COVID SymptomsTaiwan
-
Universidad Rey Juan CarlosNot yet recruitingPost COVID Syndrome | Long Covid | Long COVID Fatigue | Post COVID Syndrome Long Covid
-
Endourage, LLCCompletedLong COVID | Long Covid19 | Post-Acute COVID-19 | Long Haul COVID | Long-Haul COVID-19 | Post-Acute COVID-19 SyndromeUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingLong COVID | Post COVID Syndrome | Long COVID-19 Syndrome | Long COVID SyndromeNetherlands
-
Anxiety Relief CenterCompleted
-
Rutger LalieuDaVinci KliniekActive, not recruitingLong COVID | Long Covid19 | Long COVID-19 Syndrome | Long Covid 19Netherlands
-
University of LouisvilleRecruitingLong-COVID | Long COVID Syndrome | PASCUnited States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
Clinical Trials on Multi-systemic Rehabilitation
-
Uppsala UniversityPBM Sweden ABCompletedBurnout, Professional | Burnout Syndrome | Adjustment Disorders | Exhaustion; SyndromeSweden
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)CompletedAcute Decompensated Heart FailureUnited States
-
University of Colorado, DenverCompleted
-
The Integrative Care Science CenterUniversity Hospital, Linkoeping; EkhagastiftelsenUnknown
-
Sheba Medical CenterThe Gertner InstituteUnknown
-
Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie...CompletedHeart Failure | Depressive SymptomsAustria
-
Howard UniversityNational Hispanic Council on Aging (NHCOA)CompletedUrinary IncontinenceUnited States
-
University of GlasgowUnknown
-
University Hospital, Strasbourg, FranceNot yet recruitingSystemic Sclerosis | Rehabilitation | Face | Facial Involvement
-
Chang Gung UniversityCompleted